AstraZeneca PLC (AZN)
AstraZeneca's stock hits a 52-week and all-time high, driven by strong Q3 earnings and positive analyst outlooks. However, concerns linger regarding UK investments and past COVID-19 vaccine side effects.
About AstraZeneca PLC
AstraZeneca PLC is a global pharmaceutical and biotechnology company.
AstraZeneca PLC uses the ticker $AZN for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- AstraZeneca PLC (AZN) engagements near a 52-week high at 5.1M.
- AstraZeneca PLC (AZN) social dominance is up 119.42% from the previous week.
- AstraZeneca PLC (AZN) creators is up 86.46% from the previous month.
- AstraZeneca PLC (AZN) engagements is up 204.88% from the previous month.
- AstraZeneca PLC (AZN) mentions is up 130.23% from the previous month.
- AstraZeneca PLC (AZN) posts created is up 117.96% from the previous month.
- AstraZeneca PLC Engagements hit a 52-Week high of [---------] for the day
- AstraZeneca PLC Price hit a 52-Week high of $206.50 for the hour
- AstraZeneca PLC Price hit an all time of $206.50 for the hour
- AstraZeneca PLC entered the top [--] AltRank™ for the first time in [--] days
Price: $205.60
Price 24-Hour Time-Series Raw Data
AstraZeneca's stock is experiencing a significant upward trend, hitting 52-week and all-time highs, driven by strong Q3 earnings, positive analyst outlooks, and recent social media buzz highlighting strong free cash flow projections.
24-Hour: -0.04% 7-Day: 7.34% 30-Day: 117.77%
1-Year High: $205.60 on 2026-02-13
1-Year Low: $64.90 on 2025-04-10
AltRank: [---]
AltRank 24-Hour Time-Series Raw Data
AstraZeneca PLC (AZN) is currently AltRank #225 based on combined combined social and market metrics
Daily Average: [---]
[--] Week: [---] [----]
[--] Month: [--] [---]
[--] Months: [--] +44
[--] Year: [--] [----]
1-Year High: [-----] on 2025-07-06
1-Year Low: [--] on 2025-04-19
Galaxy Score: [-----]
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] +1
[--] Month: [--] +9
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2025-04-03
1-Year Low: [--] on 2025-06-29
Engagements: [-------] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [-------]
Daily Average: [-------]
[--] Week: [----------] +56%
[--] Month: [----------] +205%
[--] Months: [----------] +137%
[--] Year: [-----------] -64%
1-Year High: [---------] on 2026-02-15
1-Year Low: [------] on 2025-05-10
Engagements by network (24h): Reddit: [-----] YouTube: [------] Instagram: [-----] X: [-------] News: [---] TikTok: [-------]
Mentions: [-----] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [---]
[--] Week: [-----] +12%
[--] Month: [------] +130%
[--] Months: [------] +64%
[--] Year: [------] +8.20%
1-Year High: [-----] on 2025-10-11
1-Year Low: [---] on 2025-05-03
Mentions by network (24h): Reddit: [--] YouTube: [--] Instagram: [--] X: [---] News: [--] TikTok: [---]
Creators: [---] (24h)
Creators 24-Hour Time-Series Raw Data
[---] unique social accounts have posts mentioning AstraZeneca PLC (AZN) in the last [--] hours which is down 18% from [---] in the previous [--] hours
Daily Average: [---]
[--] Week: [-----] +12%
[--] Month: [-----] +86%
[--] Months: [------] +93%
[--] Year: [------] -20%
1-Year High: [-----] on 2025-10-11
1-Year Low: [---] on 2025-06-08
The most influential creators that mention AstraZeneca PLC in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @BreastCaConnect | [--] | [-----] | [--] | [------] |
| @AstraZenecaES | [--] | [------] | [--] | [------] |
| @tunemusicalmoments | [--] | [---------] | [--] | [-----] |
| @professordaveexplains | [--] | [---------] | [--] | [-----] |
| @yss4318 | [--] | [-----] | [--] | [-----] |
| @NiONiPardon | [--] | [------] | [--] | [-----] |
| @grok | [--] | [---------] | [--] | [-----] |
| @RobbieWillya | [--] | [--] | [--] | [-----] |
| @yaireinhorn | [--] | [------] | [--] | [-----] |
| @GlobalStatsX | [--] | [------] | [--] | [-----] |
Sentiment: 66%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 66%
Daily Average: 72%
[--] Week: 59% -14%
[--] Month: 64% -9%
[--] Months: 64% -2%
[--] Year: 64% -24%
1-Year High: 98% on 2025-05-08
1-Year Low: 7% on 2026-02-15
Most Supportive Themes:
- Oncology and Biopharma Prospects: (25%) Analysts have upgraded their outlook on AstraZeneca's performance in the oncology and biopharmaceutical sectors.
- Clinical Trial Successes: (20%) Positive outcomes from clinical trials, especially in areas like breast cancer treatment, are contributing to a favorable sentiment.
Most Critical Themes:
- UK Investment Concerns: (40%) Concerns exist regarding AstraZeneca's investments in the UK and potential changes to stock market listings, creating uncertainty.
- COVID-19 Vaccine Side Effects: (35%) Past acknowledgments of rare side effects associated with the COVID-19 vaccine continue to be a subject of discussion and criticism.
Social Dominance: 0.071%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.071%
Daily Average: 0.108%
[--] Week: 0.205% +0.111%
[--] Month: 0.119% +0.024%
[--] Months: 0.119% +0.021%
[--] Year: 0.119% +0.033%
1-Year High: 0.499% on 2025-10-11
1-Year Low: 0.057% on 2025-05-03
Market Dominance: 0.361%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.361%
Daily Average: 0%
1-Year High: 0.462% on 2025-03-12
1-Year Low: 0.165% on 2026-01-29
Market Cap: $318,660,778,975
Market Cap 24-Hour Time-Series Raw Data
Current Value: $318,660,778,975
Daily Average: $243,183,893,628
[--] Week: $317,823,625,870 +7.80%
[--] Month: $318,660,778,975 +8.90%
[--] Months: $318,660,778,975 +28%
[--] Year: $318,660,778,975 +40%
1-Year High: $318,660,778,975 on 2026-02-13
1-Year Low: $143,540,751,765 on 2026-01-29
Top AstraZeneca PLC Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"3/The main catalyst behind AstraZenecas massive growth in its product revenue is [--] positive clinical trial results that $AZN presented last year which could generate up to $10B of annual sales from these new [--] potential drugs. AstraZenecas pipeline is expected to grow even more with at least [--] () more blockbuster drugs - each with sales estimated at $1B a year by [----] on top of the [--] it currently has. https://twitter.com/i/web/status/2023387178697396496 https://twitter.com/i/web/status/2023387178697396496"
X Link @yaireinhorn 2026-02-16T13:21Z 18.5K followers, [---] engagements
"#China #AstraZeneca #TerraCarta #KingCharles Its all looking pretty murky to me BUT dont panic there are plenty of voices telling you theres nothing to see in #China its all #AbFab 🙄 https://www.theguardian.com/business/2026/jan/29/astrazeneca-invest-11bn-in-china-after-rowing-back-uk-expansion https://www.theguardian.com/business/2026/jan/29/astrazeneca-invest-11bn-in-china-after-rowing-back-uk-expansion"
X Link @DebiEvansMatron 2026-02-16T13:09Z [----] followers, [---] engagements
"@sputnik_TR Bu haberdeki mekanizma tm alar iin deil SADECE AstraZeneca ve Johnson & Johnson gibi "Adenovirs Vektr" alar iin geerlidir.++"
X Link @bufilmizlemesin 2026-02-16T12:52Z [----] followers, [----] engagements
"2/A year and a half ago AstraZenecas CEO Pascal Soriot made a bold statement that $AZN is going to make $80B in revenue by [----] - a statement which at the time seemed wildly ambitious and somewhat far fetched. Many investors and analysts were sceptical about Soriots statement since it meant that AstraZeneca would have to double its sales over the period of six years. But after AstraZeneca reported in its recent quarterly earnings report that its product revenue grew by 10% in [----] - taking $AZN sales to $59B Soriots statement doesnt seem far fetched at all."
X Link @yaireinhorn 2026-02-16T12:51Z 18.5K followers, [---] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing